Good news is, Medicare does cover necessary cataract surgery including the removal of the cataract and the addition of a ...

We recently compiled a list of the Top Investors’ Stock Portfolio: 7 Small-Cap Stocks to Invest In. In this article, we are ...

more rapid surgery that is very cost effective. New lens technology allows correction of a variety of optical aberrations that previously could not be corrected with an intraocular lens such as ...

Yasmin noted, adding: “Many eye health interventions can be cost-effective and relatively straightforward ... The Orbis clinical team used a Zeiss IOLMaster 500 to select the right lens implant, ...

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...

Bausch + Lomb Corp. (BLCO, BLCO.TO) announced that the U.S. Food and Drug Administration has approved the enVista Envy full range of ...

The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...